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Background: Patients presenting with bilateral trigeminal hypoesthesia may go on to have trigeminal isolated
sensory neuropathy, a benign, purely trigeminal neuropathy, or facial-onset sensory motor neuronopathy (FOSMN),
a malignant life-threatening condition. No diagnostic criteria can yet differentiate the two conditions at their onset.
Nor is it clear whether the two diseases are distinct entities or share common pathophysiological mechanisms.
Methods: Seeking pathophysiological and diagnostic information to distinguish these two conditions at their
onset, in this neurophysiological and morphometric study we neurophysiologically assessed function in myelinated
and unmyelinated fibres and histologically examined supraorbital nerve biopsy specimens with optic and electron
microscopy in 13 consecutive patients with recent onset trigeminal hypoesthesia and pain.
Results: The disease course distinctly differed in the 13 patients. During a mean 10 year follow-up whereas in eight
patients the disease remained relatively stable, in the other five it progressed to possibly life-threatening motor
disturbances and extra-trigeminal spread. From two to six years elapsed between the first sensory symptoms and
the onset of motor disorders. In patients with trigeminal isolated sensory neuropathy (TISN) and in those with
FOSMN neurophysiological and histological examination documented a neuronopathy manifesting with trigeminal
nerve damage selectively affecting myelinated fibres, but sparing the Ia-fibre-mediated proprioceptive reflex.
Conclusions: Although no clinical diagnostic criteria can distinguish the two conditions at onset, neurophysiological
and nerve-biopsy findings specify that in both disorders trigeminal nerve damage manifests as a dissociated
neuronopathy affecting myelinated and sparing unmyelinated fibres, thus suggesting similar pathophysiological
mechanisms.
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Trigeminal neuropathy is a relatively frequent clinical con-
dition that poses major diagnostic problems to centres
treating orofacial pain and headache [1,2]. Although most
patients have unilateral trigeminal neuropathy secondary
to focal lesions, a few present with a bilateral, symmet-
ric, initially purely sensory trigeminal neuropathy, often* Correspondence: giorgio.cruccu@uniroma1.it
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unless otherwise stated.related to connective tissue disease or seldom labelled as
idiopathic [3,4].
This condition has received attention in sparse case re-
ports, and in three main studies. In the first case series,
Spillane and Wells in 1959, described 16 patients with a
purely sensory, unilateral or bilateral, trigeminal neur-
opathy [5]. Several years later, Lecky and colleagues re-
ported 13 patients with idiopathic sensory disturbances
restricted to the trigeminal territory, and referred to this
condition as “idiopathic trigeminal sensory neuropathy”
[3]. More recently, Vucic and colleagues demonstratedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vere motor involvement might ultimately develop [6,7].
They studied nine patients with bilateral facial-onset
sensory deficits in whom, after a mean of 4 years, motor
deficits developed and progressed in a rostral-caudal dir-
ection. In two autopsy studies, Vucic et al. specified that
the disease primarily involved cell bodies in the sensory
ganglia and motor nuclei and named this condition “facial
onset sensory and motor neuronopathy” (FOSMN) [6-8].
Some reports suggest that FOSMN is a primary neu-
rodegenerative disorder resembling amyotrophic lateral
sclerosis, others that it is an immune-mediated neur-
opathy [8-13].
These studies indicate that a recent onset bilateral tri-
geminal sensory hypoesthesia may subsequently follow one
of two clinical courses: in some patients the disease will re-
main a trigeminal isolated sensory neuropathy (TISN) in
others it will progress to FOSMN, a life-threatening condi-
tion manifesting with severe motor involvement.
No diagnostic criteria can differentiate these two con-
ditions. Nor do we know whether they are distinct dis-
ease entities or share similar pathophysiological features.
Having this information would make it easier to predict
a favourable or unfavourable outcome, and help in plan-
ning the most appropriate treatment.
Seeking pathophysiological and diagnostic information
to distinguish these two conditions, we enrolled 13 con-
secutive patients presenting with bilateral facial sensory
hypoesthesia, did complete neurophysiological trigemi-
nal function testing (assessing all myelinated and unmy-
elinated fibre groups), and in 10 patients analysed by light
and electron microscopy the morphometric features in
supraorbital nerve biopsy samples.Methods
In the period 1997-2013, in the Policlinico Umberto I and
the Ospedale Sant’Andrea (both being University Hospitals
of the Sapienza University of Rome), we enrolled 13 con-
secutive patients with recent onset bilateral trigeminal
hypoesthesia and pain (Table 1). Exclusion criteria were
connective tissue disease, cognitive disturbances, and other
neurological diseases. All patients gave their informed con-
sent to the procedures and the publication of clinical
details. The Institutional Review Board of the Policlinico
Umberto I – Sapienza University approved the protocol.Clinical, neuroimaging and laboratory investigations
All patients underwent a detailed neurological examin-
ation using bedside tools. Trigeminal and extra-trigeminal
sensory function were assessed: touch was investigated
with a piece of cotton wool, vibration with a tuning fork
(128 Hz), and pinprick sensation with a wooden cocktail
stick. Gait impairment, and muscle strength were assessedwith the Medical Research Council score. Patients were
also asked to report dysautonomic symptoms.
All patients underwent laboratory testing, including tests
to exclude identifiable causes of trigeminal neuropathy:
autoantibody essays to detect connective tissue disease (an-
tinuclear antibodies, anti-double-stranded DNA, antinu-
clear extractable antigens, including anti Sm, anti RNP,
anti Scl70, and anti-phospholipids, antineutrophil cyto-
plasmic antibodies and anti Ro/SSA and anti-La/SSB for
Sjögren’s disease). Some patients also underwent the gen-
etic serum test for Kennedy’s disease, cholesteryl esters
and low serum cholesterol for Tangier disease, glycosphin-
golipid accumulation for Fabry’s disease, and serum-
angiotensin converting enzyme for neurosarcoidosis.
All patients underwent brain and spinal cord gadolinium-
enhanced magnetic resonance imaging (MRI).
Trigeminal neurophysiology
We tested trigeminal motor evoked potentials after
transcranial magnetic stimulation [14], the temporalis H
reflex, assessing Aα fibre (Ia fibre) in the monosynaptic
trigeminal reflex [15]. We also tested the early blink
reflex components (R1) after electrical supraorbital nerve
stimulation and the masseter inhibitory reflex (SP1) after
mental nerve stimulation, assessing Aβ fibres [16]. We re-
corded laser evoked potentials (LEPs) to investigate Aδ
nociceptors (Aδ-LEPs) and unmyelinated warmth recep-
tors (C-LEPs) [17].
All patients underwent nerve conduction studies (NCS)
using surface recording electrodes placed in the standard
manner. We recorded sensory nerve action potentials
(SNAPs) and conduction velocities from sural, ulnar and
superficial radial nerves. Other nerve function variables ex-
amined were compound motor action potential (CMAP)
amplitude and peroneal, tibial and ulnar nerve conduction
velocities. Electromyographic (EMG) investigation in-
cluded pontobulbar muscles (orbicularis oris muscle, gen-
ioglossus muscle, sternocleidomastoid muscle, masseter
muscle), limb muscles (biceps brachii, extensor digitorum
communis, first dorsal interosseus, lateral vastus, tibialis
anterior), and cervical paraspinal muscles.
Neurophysiological testing adhered to the technical re-
quirements issued by the International Federation of
Clinical Neurophysiology [18,19].
Nerve biopsy and nerve morphometry
Supraorbital nerve biopsies were performed by a trained
plastic surgeon, in a period ranging between 3 and 6
years from beginning of disease. Specimens fixed with
2% glutaraldehyde in phosphate-buffered saline (PBS) at
4°C. Samples were post-fixed in 1% osmium tetroxide in
veronal acetate buffer (pH 7.4) for 1 h at 25°C, stained
with uranyl acetate (5 mg/ml) for 1 h at 25°C, dehy-
drated in acetone and embedded in Epon 812 (EMbed
Table 1 Clinical data
Patient Gender Onset age
(years)
Onset Duration
(years)
Clinical course Pain
TISN
1 F 41 Unilateral paroxysmal
pain
20 After 15 years, bilateral ongoing pain and mild sensory deficits. YES
2 F 55 Bilateral sensory deficit 16 Stable NO
3 M 57 Unilateral paroxysmal
and ongoing pain
13 Slowly developing bilateral sensory deficit and ongoing pain. YES
4 M 63 Unilateral paroxysmal
pain
8 Slowly developing bilateral sensory deficit and ongoing pain. YES
5 F 23 Unilateral sensory deficit 8 After 5 years bilateral sensory deficit. NO
6 F 77 Bilateral paroxysmal
and ongoing pain
7 Slowly developing bilateral sensory deficit and ongoing pain. YES
7 M 55 Bilateral sensory deficit 6 After 6 years bilateral sensory deficit. NO
8 F 63 Unilateral paroxysmal
and ongoing pain
6 After 5 years bilateral sensory deficit. YES
FOSMN
9 M 49 Unilateral ongoing pain 15† Pain and sensory deficits progressively became bilateral. Motor disturbances
began after 6 years. Death 15 years after onset of sensory symptoms.
YES
10 M 50 Bilateral ongoing pain 13 Sensory deficits progressively developed bilaterally. Motor disturbances
began after 4 years. In evolution.
YES
11 F 58 Bilateral ongoing pain 8 Sensory deficits progressively developed bilaterally. Motor disturbances
began after 2 years. In evolution.
YES
12 F 53 Bilateral sensory deficit 8 Motor disturbances began after 6 years. In evolution. NO
13 F 56 Unilateral ongoing pain 6† Pain and sensory deficits progressively became bilateral. Motor disturbances
began after 4 years. Death 6 years after onset of sensory symptoms.
YES
TISN: Trigeminal isolated sensory neuropathy. FOSMN: Facial onset sensory-motor neuronopathy. †deceased.
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For each sample, semithin sections were stained with
toluidine blue for light microscopy assessment. Ultrathin
sections from tissue blocks with the proper orientation,
post-stained with uranyl acetate and lead hydroxide, were
examined under a Morgagni 268D transmission electron
microscope (FEI, Hillsboro, OR, USA). For nerve morph-
ometry a total of 20 different microscopic fields, randomly
taken from ultrathin sections from all the available fasci-
cles, were acquired at 28,000 X original magnification and
digitalized with a MegaView II charge-coupled device cam-
era (SIS, Soft Imaging System GmbH, Munster, Germany).
The digital images were analyzed with AnalySIS software
(SIS) and all myelinated and unmyelinated structures were
identified and measured. Fibre densities were calculated
and expressed as the mean number of fibres/mm2; fibre
size distributions were represented in histograms.
Morphometric data in patients with TISN and FOSMN,
were compared with supraorbital nerve findings in a 73-
year-old woman (Patient 0, Table 1, Figure 1) who had a
10-year history of constant burning pain in the face. The
pain started in the nose and left cheek, and then progres-
sively spread to involve the mouth and lips bilaterally. On
sensory examination, the patient reported hypoesthesia
on the skin of the nose and upper lips. A computedtomographic (CT) scan and two MRI scans showed no ab-
normalities consistent with her pain. To exclude trigemi-
nal neuropathy causing supraorbital nerve damage even in
a patient reporting sensory disturbances only in the lower
face we proposed a supraorbital nerve biopsy. Examin-
ation of the nerve biopsy specimen disclosed no abnor-
mality, myelinated fibres were bimodally distributed
peaking at 4.5 and 11 μm and their density was about
10,000/mm2, whereas unmyelinated fibres had a unimodal
distribution peaking at 0.8 μm and their density was about
40,000/mm2. A third MRI scan eventually disclosed abnor-
mal tissue in the left maxillary sinus. After surgery, histo-
logical examination demonstrated a well-differentiated
Malpighian cancer. We concluded that the tumor had
slowly invaded the infraorbital canal, thus explaining
the sensory disturbances and neuropathic pain on the
left side. After lengthy discussion, we tentatively at-
tributed the contralateral disturbances either to central
sensitization involving the second-order neurons that re-
ceive bilateral input from the deep trigeminal territories or
to a psychological component.
All the morphometric results had a normal distribu-
tion. Differences in normally-distributed morphomet-
ric measures were evaluated with t test for unpaired
data.
Figure 1 Light microscopy. Photomicrographs of semithin sections. left figure: normal supraorbital nerve from patient 0. Note the densely
packed myelinated fibres. right figure: supraorbital nerve from Patient 5 showing rarefied large-size myelinated fibres, whereas some small
myelinated fibres are preserved. Bar: 20 μm.
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Clinical findings
In eight patients (follow-up 10.5 ± 5.2 years), clinical dis-
turbances remained restricted to trigeminal sensory
hypoesthesia and pain without progressing to FOSMN
(Table 1). The patients’ mean age at onset was 54 ± 16
years. In some patients symptoms began with unilateral
paroxysmal pain, described as electric shock-like sensa-
tions that resembled classic trigeminal neuralgia (Table 1).
In these patients paroxysmal pain progressively disap-
peared as the sensory deficits slowly developed and
eventually stabilized. Three patients (patients 2, 5, and 7)
had sensory deficits alone. In all 8 patients repeated NCS
and needle electromyography excluded subclinical extra-
trigeminal spread.
Conversely, in five patients (follow up 10.0 ± 3.8 years)
the condition spread to cranial and limb motor nerves,
manifesting with FOSMN. Their mean age at onset was
53 ± 4 years, similar to that in the group with the isolate
trigeminal neuropathy, whereas the age range was nar-
rower, varying from 49 to 58 years (Table 1). The onset
symptoms and disease course were also similar, except
that no patient in this group had paroxysmal pain. Within
a few years (range 2-6 years) four patients manifested dys-
arthria and dysphagia, whereas one reported masticatory
weakness followed by asymmetric facial paresis. In all
five patients, the motor deficit rapidly involved other
cranial nerves but spared the oculomotor nerves. Patient
9 died 15 years after onset. Patient 13, notwithstanding
attempted therapy with intravenous immunoglobulins,
died 6 years after onset. In the other three patients, wetried intravenous immunoglobulins: two patients reported
a subjective benefit, but neither their clinical nor their
neurophysiological status improved.
Neurophysiological investigations
In both groups trigeminal motor evoked potential re-
cordings and temporalis H-reflex testing yielded normal
findings; conversely trigeminal reflex recordings showed
severe trigeminal abnormalities: the first response to be-
come absent bilaterally was the early (SP1) masseter in-
hibitory reflex after mental nerve stimulation. The early
(R1) blink reflex, however, was often delayed or even ab-
sent before the patient noticed a sensory disturbance in
the ophthalmic division. Whereas the Aδ-fibre mediated
LEPs were frequently abnormal (but less impaired than
the early trigeminal reflexes), the C-LEPs, mediated by
unmyelinated C-fibres11 were normal in all patients in
both groups.
These neurophysiological abnormality patterns in gen-
eral suggested disease progressing from the largest to the
smallest afferent fibres. The one noteworthy exception
was the normal Aα afferent-mediated temporalis H reflex
in all patients in both groups.
Whereas in patients with trigeminal isolated sensory
neuropathy NCS and EMG disclosed unremarkable find-
ings, in patients with FOSMN NCS showed slightly re-
duced ulnar and radial SNAPs in four patients, and EMG
showed denervation–reinnervation changes (large ampli-
tude, long-duration polyphasic motor unit potentials), fib-
rillation potentials, sharp waves and fasciculation in all
patients.
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In all patients the supraorbital nerve biopsy did not pro-
duce any esthetical damage or other complaint.
In biopsy specimens from the two groups of patients,
histological examination yielded almost matching find-
ings: both light and electron microscopy showed only a
Wallerian-like degeneration involving myelinated fibres,
more severe for the large Aβ- than for the small Aδ-fibre
group, with no inflammatory changes (Figures 2 and 3).
The histograms for myelinated fibres in both groups
therefore showed a unimodal distribution with loss of the
larger peak (Figure 3). Similarly, the qualitative and quan-
titative measures yielded almost matching fibre density,
peak, and maximum diameter (Table 2).
Electron microscopy of unmyelinated fibres disclosed
no collagen pockets or other abnormalities. The histo-
grams resembled those from sural nerve biopsy. Mor-
phometric data were also similar in both groups (Table 2
and Figure 3).
Discussion
Despite detailed neurophysiological and morphometric
investigations we found no clinical, neurophysiological
or neuropathological differences that could differentiate
between TISN and FOSMN. Hence, we conjecture that
the two diseases might be pathophysiologically similarFigure 2 Electron microscopy. Upper panel: low-power electron microgra
(A), 3 (B) and 11 (C). Bar: 10 μm. The supraorbital nerve contains remarkably f
C (arrow) indicates axonal breakdown and phagocytosis. Lower panel: high-
supraorbital nerve in Patient 6 (D,E) and Patient 9 (F). Bar: 10 μm in D
indicating myelin degradation in D and E. The asterisks in F and D indicate inneuropathies. Our study extends current knowledge [3-7]
by showing that TISN and FOSMN are dissociated neuro-
nopathies that fully spare unmyelinated fibres.
A dissociated neuropathy
When we quantitatively assessed trigeminal nerve fibres,
a distinctive feature in this study, the neurophysiological
data from 13 patients and morphometric findings from 10
supraorbital nerve biopsies demonstrated that both dis-
eases, TISN and FOSMN, fully spared trigeminal unmy-
elinated fibres (Table 1).
Light and electron microscopy in supraorbital nerve bi-
opsy specimens from patients with TISN and those with
FOSMN showed a variably severe axonal myelinated fibre
loss, as others have reported in these patients [3,6]. We
extend these findings by providing quantitative data show-
ing that trigeminal neuropathy affects Aβ- more severely
than Aδ-fibres. The most striking feature in the histo-
grams for myelinated fibres was the unimodal distribution
reflecting the marked reduction in or loss of the larger
peak. Normal trigeminal sensory nerves have a bimodal
distribution, similar to that for the sural nerve, as seen in
Patient 0 and demonstrated in autopsy specimens from
three healthy subjects [20]. Evidence that nerve fibre dam-
age progresses from the largest to the smallest fibre
comes also from the neurophysiological findings,phs taken on ultrathin sections from the supraorbital nerve in Patients 2
ewer large myelinated than small myelinated fibres. The macrophage in
power electron micrographs taken on ultrathin sections from the
, 5 μm in E, and 1 μm in F. Myelin debris in Schwann cells (arrows),
tact unmyelinated fibres.
Figure 3 Histograms. Histograms for myelinated (left) and unmyelinated (right) fibres. A: grand average for three autopsy specimens (Pennisi
et al. [20]). B: Patient 0. C: grand average for six patients with trigeminal isolated sensory neuropathy (TISN). D: grand average for four patients
with facial-onset sensory motor neuronopathy (FOSMN). Myelinated fibres in patients with trigeminal neuronopathy are unimodally distributed
and the two conditions yield similar histograms.
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Table 2 Morphometric data
Myelinated fibres Unmyelinated fibres
Patient Density (n/mm2) Peak (μm) Max (μm) Density (n/mm2) Peak (μm) Max (μm)
0 10000 4.5-11 14.5 40000 0.8 1.8
TISN
1 -
2 4500 5 13 30000 1.0 1.7
3 5000 5 14 35000 0.9 1.5
4 -
5 3212 2 14 43210 1.0 1.8
6 2526 3 8 52751 1.1 1.6
7 12073 3 11 36997 0.8 1.4
8 5526 3.5 11 50600 0.8 1.7
Mean ± SD 5473 ± 3421 3.6 ± 1.2 11.8 ± 2.3 41426 ± 9023 0.9 ± 0.1 1.6 ± 0.1
FOSMN
9 2500 4 8 40000 1.0 1.7
10 1150 3.5 12.5 31600 0.9 1.6
11 7829 2.5 10 54197 0.8 1.4
12 -
13 11639 3 11.5 59978 1.0 1.8
Mean ± SD 5780 ± 4855 3.3 ± 0.6 10.5 ± 2.0 46444 ± 12976 0.9 ± 0.1 1.6 ± 0.2
P >0.90 >0.60 >0.35 >0.45 >0.90 >0.90
TISN: Trigeminal isolated sensory neuropathy. FOSMN: Facial onset sensory-motor neuronopathy. P: t test between TISN and FOSMN.
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even at the earliest disease stages. Conversely, Aδ-fibre-
mediated responses were far less impaired.A neuronopathy
In patients with TISN and in those with FOSMN the
temporalis H-reflex sparing provides evidence that these
two conditions primarily affect cell bodies [6,7]. A disso-
ciated neuropathy that progressively affects the largest
then the smallest myelinated fibres should in theory
severely alter a reflex mediated by Aα afferents from
muscle spindles. Conversely, it spares the primary affer-
ents from trigeminal muscle spindles because they travel
in the motor rather than the sensory root. Equally im-
portant, rather than lying in the sensory ganglion their
cell bodies lie in the mesencephalic trigeminal nucleus
[21,22]. This unique anatomic feature also explains why
the mandibular tendon jerk (or jaw jerk) is spared in two
other trigeminal neuronopathies: Sjögren’s syndrome
and Kennedy’s disease [23,24].
Unlike previous studies that used a hand-held reflex
hammer to elicit the mandibular tendon jerk we used
the temporalis H reflex to avoid possible interference
from temporomandibular dysfunction or malocclusion,
conditions that can induce abnormalities or even an ab-
sent reflex response to the hand-held reflex hammer [25].Differential diagnosis
The variable clinical presentation at the onset of bilateral
trigeminal neuropathy makes the differential diagnosis with
the various possible trigeminal nerve diseases a challenging
task [26]. Several patients in our series had unilateral parox-
ysmal pain as the first symptom. Hence, a few patients
might be initially diagnosed as having trigeminal neuralgia.
This diagnostic error can be avoided by routinely including
trigeminal reflex testing in the diagnostic work-up. Accord-
ing to European and American guidelines, the early (Aβ-
mediated) responses are normal in over 90% of patients
with classic trigeminal neuralgia, whereas in patients with
trigeminal neuropathy they are always abnormal [27,28].
Bilateral trigeminal neuropathy is often related to con-
nective tissue disease [4]. Trigeminal neuropathy sometimes
heralds the onset of systemic sclerosis, mixed connective tis-
sue disease, or Sjögren's syndrome [29]. Whereas Sjøgren’s
syndrome is easily recognised by its other typical symptoms,
xerophthalmia and xerostomia, other connective tissue dis-
eases may be more difficult to differentiate at an early stage.
A condition that closely resembles the FOSMN syn-
drome is the Kennedy’s disease, an X-linked hereditary
disease that progressively affects primary sensory neu-
rons and motoneurons [30]. The onset can occasionally
be trigeminal, and thus male patients with this type of
trigeminal neuronopathy must undergo genetic testing
for Kennedy’s disease.
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bulbar-onset amyotrophic lateral sclerosis, the various
forms of Tangier and Fabry’s disease, neurosarcoidosis,
and syringobulbia, are easily ruled out by clinical history
and examination [3,6,7,31].Pain mechanisms
In our patients with TISN and FOSMN, the dissociated
nerve fibre involvement should provide relatively sound in-
formation about how specific nerve-fibre groups intervene
in the pathophysiology of the various types of neuropathic
pains [32], in particular ongoing pain due to deafferen-
tation. Our findings on pain nevertheless go against classic
notions about pain mechanisms. First, histological findings
and neurophysiological testing showed that the unmyelin-
ated fibres were fully spared. Secondly, during the disease
course, as the sensory deficit progressively increased in se-
verity, i.e. more and more primary neurons degenerated,
the pain tended to disappear. These findings clearly argue
against spontaneous hyperactivity in deafferented nocicep-
tive second-order neurons [32]. A possible explanation
for these contrasting results on the relationship between
myelinated nerve fibres and the development of neuro-
pathic pain lies in the imbalanced input from myelinated
and unmyelinated nerve fibres onto the second-order
neurons [33].Conclusions
Because TISN and FOSMN share almost identical clin-
ical, neurophysiological and morphometric trigeminal
features at onset, no currently available diagnostic tech-
niques can predict their clinical course. Nor can we pre-
dict whether patients with bilateral trigeminal sensory
hypoesthesia and pain will ultimately have FOSMN. In
TISN as well as in FOSMN, trigeminal nerve damage
manifests as a dissociated neuronopathy affecting mye-
linated and sparing unmyelinated fibres. Although we
cannot conclude that TISN and FOSMN are the same
disease, given that the two conditions cause similar tri-
geminal nerve damage they might also share similar
pathogenetic mechanisms. In this case, the different
course of disease might be explained—as a few patients
were reported to respond to immunomodulating drugs
[11,12]—by dysimmune mecanisms with different targets
in TISN and FOSMN.
Those who work in centres specialized in orofacial
pain or headache should be aware that a patient who
initially manifests sensory disturbances on one side
alone may later go on to manifest trigeminal bilateral
neuronopathy. Hence, they should refer patients who
begin to experience contralateral sensory symptoms for
detailed diagnostic investigations. Although no therapy is
currently effective, an early diagnosis would inform thepatient about the outcome and exclude other possibly
treatable causes.
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